Institut Biochimique SA

Yaral Pharma, a recently-launched US generics subsidiary of Institut Biochimique SA , will be expanding its partnership with life sciences service provider Eversana. Having supported the company thro

Financings Life science start-up companies raised a total of $1.8 billion in the first quarter of 2016, $579 million less than the previous quarter. Thirty-seven biopharma companies combined for $1.3

FDA’s Office of Prescription Drug Promotion’s workload is getting lighter in one area: it is finding fewer objectionable promotional pieces. This year the office has issued only two letters to drug sp